Diagnosis, management and prevention of ventilator-associated pneumonia in the UK

European Journal of Anaesthesiology

Volumn 24, Issue 11, 2007, Pages 971-977

  Hunter, John ^a   Annadurai, S ^b   Rothwell, M ^a  

^a MACCLESFIELD DISTRICT GENERAL HOSPITAL   (United Kingdom)

^b Alder Hay Hospital   (United Kingdom)

Author keywords

Critical care; Diagnosis; Pneumonia; Prevention and control; Questionnaire; Ventilator associated

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE;

ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; COMBINATION CHEMOTHERAPY; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MONOTHERAPY; MOUTH HYGIENE; PATIENT POSITIONING; PHYSICIAN; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; TRACHEOSTOMY; UNITED KINGDOM; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; DRUG UTILIZATION; GREAT BRITAIN; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; INTENSIVE CARE; PNEUMONIA, VENTILATOR-ASSOCIATED; QUESTIONNAIRES; TRACHEA;

EID: 35148894525     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021507001123     Document Type: Article

References (48)

1. Vincent JL, Bihari DJ, Suter PM et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995; 274: 639-644.
2. Heyland DK, Cook DJ, Griffith L et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159: 1249-1256.
3. Fagon JY, Chastre AJ, Hance AJ et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94: 281-288.
4. Celis R, Torres A, Gatell JM, Almela M, Rodriguez-Roisin R, Agusti-Vidal A. Nosocomial pneumonia. A mulitivariate analysis of risk and prognosis. Chest 1988; 93: 318-324.
5. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165: 867-903.
6. Haley RW, Hooton TM, Culver TH et al. Nosocomial infection in US hospitals 1975-76. Estimated frequency by selected characteristics of patients. Am J Med 1981; 70: 947-959.
7. Chevret S, Hemmer M, Carlet J et al. Incidence and risk factors of pneumonia acquired in intensive care units. Results from a multi-centre prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia. Intensive Care Med 1993; 19: 256-264.
8. Shorr AF, Kollef MH. Ventilator-associated pneumonia. Insights from recent trials. Chest 2005; 128: 583S-591S.
9. Sierra R, Benitez E, Leon C, Rello J. Prevention and diagnosis of ventilator-associated pneumonia: a survey on current practices in Southern Spanish ICU's. Chest 2005; 128: 1667-1673.
10. Rello J, Lorente C, Bodi M, Diaz E, Ricart M, Kollef MH. Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia? A survey based on the opinions of an international panel of intensivists. Chest 2002; 122: 656-661.
11. Kollef MH. The prevention of ventilator-associated pneumonia. N Engl J Med 1999; 340: 627-634.
12. Hubmayr RD, Burchardi H, Elliot M et al. American Thoracic Society Assembly on Critical Care; European Respiratory Society; European Society of Intensive Care Medicine; Societe de Reanimation de Langue Francaise. Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia-Chicago, Illinois, May 2002. Intensive Care Med 2002; 28: 1521-1536.
13. CMA Medical Data. Directory of Operating Theatres and Departments of Surgery. Cambridge: CMA Medical Data, 2003.
14. Wunderink RG. Radiologic diagnosis of ventilator-associated pneumonia. Chest 2000; 117: 188S-190S.
15. Meduri GU, Mauldin GL, Wunderink RG et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 1994; 106: 221-235.
16. Jourdain B, Novara A, Joly-Guillou ML et al. Role of quantitative cultures of endotracheal aspirates in the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 1995; 152: 241-246.
17. Marquette CH, Copin MC, Wallet F et al. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med 1995; 151: 1878-1888.
18. Sanchez-Nieto JM, Torres A, Garcia-Cordoba F et al. Impact of invasive and non-invasive quantitative culture sampling on outcome of ventilator-associated pneumonia. Am J Respir Crit Care Med 1998; 157: 371-376.
19. Ruiz M, Torres A, Ewig S et al. Non-invasive vs. invasive microbial investigation in ventilator associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med 2000; 162: 119-125.
20. Camargo LF, De Marco FV, Barbas CS et al. Ventilator associated pneumonia: comparison between quantitative and qualitative cultures of tracheal aspirates. Crit Care 2004; 8: R422-R430.
21. Wearden PD, Chendrasekhar A, Timberlake GA. Comparison of nonbronchoscopic techniques with bronchoscopic brushing in the diagnosis of ventilator-associated pneumonia. J Trauma 1996; 41: 703-707.
22. Shorr AF, Sherner JH, Jackson WL et al. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2005; 33: 46-53.
23. Mehta R, Niederman MS. Adequate empirical therapy minimizes the impact of diagnostic methods in patients with ventilator-associated pneumonia. Crit Care Med 2000; 28: 3092-3094.
24. Luna CM, Vujacich P, Niederman MS et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111: 676-685.
25. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1995; 115: 462-474.
26. American Thoracic Society& Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
27. Torres A, Aznar R, Gatell JM et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142: 523-528.
28. Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L. Beta lactam monotherapy vs. beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 2004; 328: 668-681.
29. Rubinstein E, Lode H, Grassi C. Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group. Clin Infect Dis 1995; 20: 1217-1228.
30. Damas P, Garweg C, Monchi M et al. Combination therapy vs. monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia. Crit Care 2006; 10: R52.
31. Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29: 1109-1115.
32. Kollef MH. Is there a role for antibiotic cycling in the intensive care unit? Crit Care Med 2001; 29(4 Suppl): N135-N142.
33. Kollef MH, Vlasnik J, Sharpless L, Pasque C, Murphy D, Fraser V. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156: 1040-1048.
34. Gruson D, Hilbert G, Vargas F et al. Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Am J Respir Crit Care Med 2000; 162: 837-843.
35. Chastre J, Wolff M, Fagon JY et al. Comparison of 8 vs. 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290: 2588-2598.
36. Dodek P, Keenan S, Cook D et al. Evidence-based clinical practice guideline for the prevention of ventilatorassociated pneumonia. Ann Intern Med 2004; 141: 305-313.
37. Heyland DK, Cook DJ, Dodek PM. Prevention of ventilator-associated pneumonia: current practice in Canadian intensive care units. J Crit Care 2002; 17: 161-167.
38. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999; 354: 1851-1858.
39. Kress JP, Pohlman AS, O'Connor MF et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342: 1471-1477.
40. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group. Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. BMJ 1993; 307: 525-532.
41. Heyland DK, Cook DJ, Jaeschke R, Griffith L, Lee HN, Guyatt GH. Selective decontamination of the digestive tract. An overview. Chest 1994; 105: 1221-1229.
42. Rumbak MJ, Newton M, Truncale T et al. A prospective, randomized, study comparing early percutaneous dilational tracheotomy to prolonged translaryngeal intubation (delayed tracheotomy) in critically ill medical patients. Crit Care Med 2004; 32: 1689-1694.
43. DeRiso 2nd AJ, Ladowski JS, Dillon TA, Justice JW, Peterson AC. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use inpatients undergoing heart surgery. Chest 1996; 109: 1556-1561.
44. Sirvent JM, Torres A, El-Ebiary M, Castro P, de Batlle J, Bonet A. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Am J Respir Care Med 1997; 155: 1729-1734.
45. Nourdine K, Combes P, Carton MJ et al. Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey. Intensive Care Med 1999; 25: 567-573.
46. Valles J, Artigas A, Rello J et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995; 122: 179-186.
47. Young PJ, Basson C, Hamilton D, Ridley SA. The pressure limited tracheal tube cuff: prevention of aspiration of oropharyngeal fluid to the lungs. Brit J Anaesth 1998; 81: 823P-824P.
48. Seegobin RD, van Hasselt GL. Aspiration beyond endotracheal cuffs. Can Anaesth Soc J 1986; 33: 273-279.